The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2022

Filed:

Feb. 01, 2021
Applicant:

Seattle Children's Hospital, Seattle, WA (US);

Inventors:

Ashley M. Vaughan, Seattle, WA (US);

Stefan H. I. Kappe, Seattle, WA (US);

Dorender A. Dankwa, Seattle, WA (US);

Assignee:

SEATTLE CHILDREN'S HOSPITAL, Seattle, WA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/002 (2006.01); A61K 39/015 (2006.01); C07K 14/445 (2006.01); C12N 1/36 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/015 (2013.01); C07K 14/445 (2013.01); C12N 1/36 (2013.01); A61K 2039/522 (2013.01); C12N 2310/20 (2017.05);
Abstract

The disclosure relates to doubly attenuated malaria parasites that have had the functionality of LISP2 and PlasMei2 genes interrupted through genetic manipulation. The double attenuated malaria parasites disclosed herein are useful for methods and compositions for stimulating of vertebrate host immune systems because of the complete cessation of lifecycle progression in the late liver stage, while providing a comprehensive antigenic presentation representing wildtype liver stage parasites. The disclosure also relates to the additional blood stage and gametocyte antigens to compositions of genetically attenuated malaria parasites (GAPs) to enhance efficient immune stimulation and prevention of disease and transmission related to the presence of blood stage parasites.


Find Patent Forward Citations

Loading…